Pyridoxal and pyridoxal phosphate have been reported to activate T cell lines transduced with the 7.G5 TCR, a receptor recently characterized for its ability to recognize MR1-presented ligands across a broad range of tumor types, including both hematologic and solid malignancies, thus demonstrating functional “pan-cancer” reactivity (54). The gene discussed is MR1; the disease is neoplasm.